Back to search

National and Kapodistrian University of Athens

Η συμβολή του γονιδίου LILRA3 στην παθογένεια του συνδρόμου SJOGREN

Abstract

dc:description

Title: Association of LILRA3 gene with lympomagenesis risk in young SS patients Primary Sjögren’s Syndrome (pSS) is a systematic autoimmune disease, characterized by increased risk for B non-Hodgkin lymphoma (B-NHL) development. While the deleted variation of the Leukocyte immunoglobulin-like receptor A3 (LILRA3) gene has been identified as a risk factor for both lymphomagenesis and pSS development in Caucasian populations, the functional LILRA3 variant was found to increase susceptibility for Rheumatoid Arthritis (RA), Systemic Lupus Erythematosous (SLE) and pSS in Chinese population. Moreover functional LILRA3 gene has been linked to increased LILRA3 protein serum levels, as previously reported. LILRA3 is a soluble immunoreceptor which binds to MHC-I molecules, is secreted by monocytes and B-cells and induces NK and CD8⁺ T cells production, triggering inflammatory responses. The aim of our case-control study was to estimate the prevalence of LILRA3 gene variants, quantitate LILRA3 protein serum levels and explore potential clinical and serological associations in pSS population. 402 patients meeting the classification criteria for pSS (ACR/EULAR classification criteria, 2016) and 381 healthy Controls (ΗC) of similar age and sex distribution all of Greek origin were included. pSS patients were further stratified according to the presence and the type of lymphoma in 301 SS-nL (SS-non Lymphoma group) and in 101 SS-L (Lymphoma) group. On the basis of the age of SS onset, SS patients were further stratified into younger (≤40 years) [SS-nL ≤40 (n = 52), SS-L ≤40 (n = 23)] and older (>40 years) age of disease onset [SS-nL >40 years (n = 249), SS-L >40 years (n = 78)]. LILRA3 gene polymorphisms were detected using polymerase chain reaction (PCR). We identified three genetic variations: homozygous-non deleted or functional or wild type type (+/+), heterozygous (+/-) and homozygous deleted (-/-). LILRA3 protein serum levels were measured by Enzyme-Linked Immunosorbent Assay (ELISA). All statistical analyses were performed using SPSS and Graphpad Prism 5 and the level of statistical significance was defined to 5%. There was no difference in the frequency of LILRA3 genetic variants between the whole pSS population and HC. When pSS patients were stratified according to the age of disease onset, only the SS-L group with disease onset ≤ 40 years displayed statistically significant higher rates of the wild type variant of the LILRA3 gene compared to HC (100% vs 82.9%, p=0.03). In line with this observation, LILRA3 protein serum levels were also found to be significantly elevated in SS-L group ≤40 years, compared to SS-nL and HC ≤40 years (1.77 ± 1.45 ng/mL vs 0.89 ± 0.61 ng/mL vs. 0.46 ± 0.43 ng/mL, p-values 0.049 and 0.001, respectively). Moreover, LILRA3 serum levels were also significantly increased in SS-L group ≤40 years compared to those with disease onset later in life (1.77 ± 1.45 ng/mL vs 0.66 ± 0.89 ng/mL p=0.007). While no differences in LILRA3 gene variants were detected between pSS and HC groups, increased rates of the functional wild type LILRA3 gene together with heightened LILRA3 serum protein levels were found in SS-L patients with age of SS onset ≤40 years. Given the previously reported role of the LILRA3 functional variant in promoting inflammation and the aggressive clinical phenotypes observed in younger SS individuals, the present findings further support a potential contributory role of the LILRA3 variant in lymphoproliferaion related to young onset pSS, through fueling of chronic inflammatory responses.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Argyriou, Evangelia
  • Αργυρίου, Ευαγγελία

Subjects

dc:subject × 9

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/49825

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Argyriou, Evangelia; Αργυρίου, Ευαγγελία. Η συμβολή του γονιδίου LILRA3 στην παθογένεια του συνδρόμου SJOGREN. National and Kapodistrian University of Athens, 2021. http://hdl.handle.net/10442/hedi/49825